AngioScore brings in $30mm through its Series E round
AngioScore (angioplasty catheters) has raised $30mm through the closing of its Series E venture round. Telegraph Hill Partners led the financing and was joined by all of the company's current institutional investors including Psilos Group Managers, QuestMark Partners, UV Partners, California Technology Ventures, and InnoMed Ventures. Thomas Weisel was the placement agent.
- Medical Devices
Surgical Equipment & Devices
- Minimally or Less Invasive
- Surgical Equipment & Devices
- Venture Financing
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com